Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
02 2023
Historique:
received: 03 02 2022
accepted: 19 12 2022
pubmed: 5 1 2023
medline: 25 2 2023
entrez: 4 1 2023
Statut: ppublish

Résumé

Acute viral infections can have durable functional impacts on the immune system long after recovery, but how they affect homeostatic immune states and responses to future perturbations remain poorly understood

Identifiants

pubmed: 36599369
doi: 10.1038/s41586-022-05670-5
pii: 10.1038/s41586-022-05670-5
pmc: PMC10481789
mid: NIHMS1923412
doi:

Substances chimiques

Influenza Vaccines 0
Interleukin-15 0
Toll-Like Receptors 0
IFNG protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

752-761

Subventions

Organisme : NCI NIH HHS
ID : 75N91019D00024
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AI001359
Pays : United States

Investigateurs

Princess Barber (P)
Daly Cantave (D)
Anne Carmona (A)
Jean Hammer (J)
Alaina K Magnani (AK)
Valerie Mohammed (V)
Cindy Palmer (C)
Deitra Shipman (D)

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Sci Transl Med. 2021 Jun 16;13(598):
pubmed: 34103408
Trends Immunol. 2022 Sep;43(9):696-705
pubmed: 35907675
Nat Rev Immunol. 2016 Jun;16(6):392-400
pubmed: 27157064
Nat Immunol. 2011 Jul 10;12(8):786-95
pubmed: 21743478
Cell. 2014 Apr 10;157(2):499-513
pubmed: 24725414
Nat Rev Drug Discov. 2021 Jun;20(6):454-475
pubmed: 33824489
BMC Biotechnol. 2017 Jul 10;17(1):61
pubmed: 28693542
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Nat Commun. 2019 Jul 26;10(1):3338
pubmed: 31350391
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12300-6
pubmed: 25136102
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
BMC Bioinformatics. 2019 Apr 16;20(1):189
pubmed: 30991955
Innovation (Camb). 2021 Jul 01;2(3):100141
pubmed: 34557778
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Science. 1996 Jun 28;272(5270):1947-50
pubmed: 8658169
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Cell. 2021 Jul 22;184(15):3915-3935.e21
pubmed: 34174187
Cell. 2021 Apr 1;184(7):1671-1692
pubmed: 33743212
PLoS Pathog. 2015 Jun 12;11(6):e1004869
pubmed: 26070066
J Exp Med. 2017 Jul 3;214(7):2139-2152
pubmed: 28637884
Biomedicines. 2021 Sep 17;9(9):
pubmed: 34572439
Nat Methods. 2017 Sep;14(9):865-868
pubmed: 28759029
Sci Transl Med. 2020 Jul 1;12(550):
pubmed: 32513867
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nat Immunol. 2001 Feb;2(2):157-64
pubmed: 11175814
Cell Mol Immunol. 2021 Sep;18(9):2128-2139
pubmed: 34290398
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Cell. 2021 Apr 1;184(7):1836-1857.e22
pubmed: 33713619
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Commun. 2020 Jul 6;11(1):3434
pubmed: 32632085
Nat Commun. 2019 May 22;10(1):2263
pubmed: 31118448
Nat Commun. 2022 Apr 19;13(1):2099
pubmed: 35440536
Open Forum Infect Dis. 2021 Aug 31;8(9):ofab448
pubmed: 34584899
Nat Rev Immunol. 2017 Jun;17(6):391-400
pubmed: 28480897
Cell Mol Immunol. 2020 Dec;17(12):1257-1265
pubmed: 32210395
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Nat Cell Biol. 2021 Jun;23(6):620-630
pubmed: 34108657
Bioinformatics. 2021 Apr 19;37(2):192-201
pubmed: 32730587
MMWR Morb Mortal Wkly Rep. 2021 Jul 23;70(29):1013-1019
pubmed: 34292924
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
Nat Med. 2022 Feb;28(2):363-372
pubmed: 35177857
Cytometry A. 2020 Oct;97(10):1044-1051
pubmed: 32830910
F1000Res. 2020 Jan 27;9:47
pubmed: 32789006
Annu Rev Virol. 2021 Sep 29;8(1):393-414
pubmed: 34081540
Nat Med. 2020 Apr;26(4):618-629
pubmed: 32094927
JCI Insight. 2021 Jan 11;6(1):
pubmed: 33232303
Front Immunol. 2018 Nov 20;9:2692
pubmed: 30515169
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6686-6696
pubmed: 32161126
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Trends Immunol. 2015 Aug;36(8):479-93
pubmed: 26187853
Immunity. 2021 Jun 8;54(6):1257-1275.e8
pubmed: 34051148
Lancet Infect Dis. 2023 Jan;23(1):e34-e42
pubmed: 36037824
Nat Rev Immunol. 2020 Jun;20(6):375-388
pubmed: 32132681
Nat Med. 2016 Dec;22(12):1439-1447
pubmed: 27798615
Nat Immunol. 2014 Feb;15(2):195-204
pubmed: 24336226
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
J Infect Dis. 2011 Apr 1;203(7):921-9
pubmed: 21357945
Nat Commun. 2021 Feb 22;12(1):1221
pubmed: 33619281
J Immunol. 2009 Feb 15;182(4):1962-71
pubmed: 19201849
Sci Immunol. 2022 Jan 07;7(67):eabm5505
pubmed: 34995097
Hum Immunol. 2011 Aug;72(8):627-31
pubmed: 21539877
Cell. 2012 Sep 14;150(6):1235-48
pubmed: 22980983
J Immunol. 2021 Feb 1;206(3):455-462
pubmed: 33468558
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
Eur J Immunol. 2015 Jul;45(7):1926-33
pubmed: 25903796
Nat Biotechnol. 2018 Jan;36(1):89-94
pubmed: 29227470
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Ecol Evol. 2014 Sep;4(18):3514-24
pubmed: 25478144
Sci Transl Med. 2011 Jun 1;3(85):85ra48
pubmed: 21632986
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Cell. 2020 Sep 17;182(6):1419-1440.e23
pubmed: 32810438
Nat Immunol. 2022 Feb;23(2):210-216
pubmed: 35027728
Cell Rep. 2019 Feb 5;26(6):1627-1640.e7
pubmed: 30726743
J Exp Med. 2017 Jul 3;214(7):1913-1923
pubmed: 28606987
Science. 2019 Nov 1;366(6465):599-606
pubmed: 31672891
Trends Immunol. 2020 Jun;41(6):457-465
pubmed: 32340868
Sci Adv. 2021 Mar 5;7(10):
pubmed: 33674317
Science. 2020 Sep 4;369(6508):1210-1220
pubmed: 32788292
Nat Biotechnol. 2014 Sep;32(9):896-902
pubmed: 25150836
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Nat Commun. 2021 Feb 19;12(1):1162
pubmed: 33608522
PLoS Pathog. 2021 Oct 25;17(10):e1009928
pubmed: 34695164
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937

Auteurs

Rachel Sparks (R)

Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.

William W Lau (WW)

Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.

Can Liu (C)

Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
Graduate Program in Biological Sciences, University of Maryland, College Park, MD, USA.

Kyu Lee Han (KL)

NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.

Kiera L Vrindten (KL)

Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.

Guangping Sun (G)

Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.

Milann Cox (M)

Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.

Sarah F Andrews (SF)

Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.

Neha Bansal (N)

Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.

Laura E Failla (LE)

Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.

Jody Manischewitz (J)

Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.

Gabrielle Grubbs (G)

Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.

Lisa R King (LR)

Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.

Galina Koroleva (G)

NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.

Stephanie Leimenstoll (S)

Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, USA.

LaQuita Snow (L)

Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, USA.
Johns Hopkins University, Baltimore, MD, USA.

Jinguo Chen (J)

NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.

Juanjie Tang (J)

Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.

Amrita Mukherjee (A)

NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.

Brian A Sellers (BA)

NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.

Richard Apps (R)

NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.

Adrian B McDermott (AB)

Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.

Andrew J Martins (AJ)

Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.

Evan M Bloch (EM)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Hana Golding (H)

Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.

Surender Khurana (S)

Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.

John S Tsang (JS)

Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA. john.tsang@yale.edu.
NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA. john.tsang@yale.edu.
Yale Center for Systems and Engineering Immunology and Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. john.tsang@yale.edu.
Department of Biomedical Engineering, Yale University, New Haven, CT, USA. john.tsang@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH